Testing effectiveness (Phase 2)UnknownNCT04445220
What this trial is testing
Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy
Who this might be right for
COVID-19Acute Kidney InjurySepsis
Sentien Biotechnologies, Inc. 22